Cathay Biotech Inc. (SHA:688065)

Cathay Biotech Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	2,819	2,067	2,332	2,296	1,488
Other Revenue	138.84	47.17	108.67	67.67	9.49
Revenue	2,958	2,114	2,441	2,363	1,497
Revenue Growth (YoY)	39.91%	-13.39%	3.28%	57.86%	-21.87%
Cost of Revenue	2,121	1,535	1,612	1,526	808.77
Gross Profit	836.44	579.23	829.2	837.21	688.42
Selling, General & Admin	222	221.61	232.28	175.11	143.25
Research & Development	233.34	189.13	187.71	133.53	84.3
Other Operating Expenses	13.83	9.21	-4.09	22.94	10.45
Operating Expenses	472.51	413.68	422.59	337.95	241.23
Operating Income	363.93	165.55	406.61	499.25	447.19
Interest Expense	-27.43	-32.17	-20.01	-16.29	-3.86
Interest & Investment Income	160.75	219.77	236.78	229.61	52.18
Earnings From Equity Investments	-8.95	-7.82	-3.71	-	-
Currency Exchange Gain (Loss)	36.73	29.59	82.97	-14.14	-18.26
Other Non Operating Income (Expenses)	-6.04	-5.7	-4.61	-0.59	-0.32
EBT Excluding Unusual Items	518.99	369.22	698.03	697.84	476.93
Gain (Loss) on Sale of Investments	-	-	-	-	9.15
Gain (Loss) on Sale of Assets	0.42	-0.01	0.07	-	-
Asset Writedown	-0.05	-0.26	-0.02	-0.06	-1.15
Other Unusual Items	28.66	79.97	-2.09	26.66	35.85
Pretax Income	548.02	448.92	695.99	724.45	520.79
Income Tax Expense	73.43	40.39	83.34	90.94	63.45
Earnings From Continuing Operations	474.59	408.54	612.65	633.51	457.34
Minority Interest in Earnings	14.37	-42.01	-59.39	-38.79	0.33
Net Income	488.96	366.52	553.27	594.72	457.67
Net Income to Common	488.96	366.52	553.27	594.72	457.67
Net Income Growth	33.41%	-33.75%	-6.97%	29.94%	-4.43%
Shares Outstanding (Basic)	582	582	582	583	543
Shares Outstanding (Diluted)	582	582	582	583	543
Shares Change (YoY)	0.05%	-0.10%	-0.11%	7.38%	6.91%
EPS (Basic)	0.84	0.63	0.95	1.02	0.84
EPS (Diluted)	0.84	0.63	0.95	1.02	0.84
EPS Growth	33.33%	-33.68%	-6.86%	21.01%	-10.61%
Free Cash Flow	-22.38	-1,000	-3,395	-880.49	-248.15
Free Cash Flow Per Share	-0.04	-1.72	-5.83	-1.51	-0.46
Dividend Per Share	0.400	0.190	0.180	0.321	0.571
Dividend Growth	110.53%	5.56%	-43.99%	-43.75%	-
Gross Margin	28.28%	27.40%	33.97%	35.42%	45.98%
Operating Margin	12.30%	7.83%	16.66%	21.12%	29.87%
Profit Margin	16.53%	17.34%	22.66%	25.16%	30.57%
Free Cash Flow Margin	-0.76%	-47.32%	-139.06%	-37.25%	-16.57%
EBITDA	679.85	451.26	671.73	667.79	565.51
EBITDA Margin	22.98%	21.34%	27.52%	28.25%	37.77%
D&A For EBITDA	315.92	285.72	265.12	168.54	118.32
EBIT	363.93	165.55	406.61	499.25	447.19
EBIT Margin	12.30%	7.83%	16.66%	21.12%	29.87%
Effective Tax Rate	13.40%	9.00%	11.97%	12.55%	12.18%
Revenue as Reported	2,958	2,114	2,441	2,363	1,497

Source: S&P Global Market Intelligence. Standard template. Financial Sources.